Fermenta Biotech Company Description

Fermenta Biotech Limited, together with its subsidiaries, manufactures and markets chemicals, bulk drugs, enzymes in India, Europe, the United States, and internationally.

The company engages in the pharmaceutical formulations and environmental solutions; rents and sales properties; and sports and health awareness/education activities.

It offers various variants of vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder used in applications, such as pharmaceuticals, dietary and nutritional supplements, feed, injectables, soft gel capsules, premixes, food and beverage fortification, veterinary, feed and rodenticides; pharmaceutical ingredients comprising of phenyramidol and silicon dry powder; nutritional premixes; and enzymes, used in pharmaceuticals, food and fragrances, oleo, biodiesel, leather, fine chemical, bio-plastics, and cosmetic industries.

In addition, the company provides engages in the design, engineering, procurement, and construction of water and wastewater treatment plants; and offers operations and maintenance services, as well as property development business.

The company was formerly known as DIL Limited. Fermenta Biotech Limited was incorporated in 1951 and is based in Thane, India.

Fermenta Biotech Limited operates as a subsidiary of DVK Investments Private Limited.

Fermenta Biotech Limited

Country	India
Founded	1951
Industry	Pharmaceutical Preparations
Employees	558
CEO	Prashant Nagre

Contact Details

Address: DIL Complex Thane, Maharashtra 400610 India
Phone	91 22 6798 0888
Website	fermentabiotech.com

Stock Details

Ticker Symbol	506414
Exchange	Bombay Stock Exchange
Fiscal Year	April - March
Reporting Currency	INR
SIC Code	2834

Key Executives

Name	Position
Prashant Nagre	Chief Executive Officer
Sumesh Gandhi	Chief Financial Officer